Sept. 13, 2022

Japanese patent granted for theranostic assay platform

Aug. 02, 2022

Chinese patent granted for theranostic assay platform

Mar. 28, 2022

TÜV Süd granted an ISO 13485:2016 Certificate for the Akribes Quality Management System (QMS)

The QMS at Akribes complies with the DIN EN ISO13485:2016 standard for medical devices. The certificate covers the scope of “Design and Development, Production and Sales of lab-on-a-chip devices and IVD software for diagnostics and therapy recommendation for chronic/non-healing wounds.

Dec. 02-03, 2021

Invited talk at 4th Nuremberg Wound Congress

Wolff-Winiski B: Functional analyses of exudates from chronic wound patients.

Nov. 17-18, 2021

Invited talk at 5th Dermatology Drug Development Summit for Inflammatory Skin Diseases, Boston

Wolff-Winiski B: New treatment options for chronic wounds.

June 02, 2021

EU patent granted for selected drugs

Mar. 03, 2021

EU patent granted for drug combinations

Dec. 03-04, 2020

Invited talk at 3rd Nuremberg Wound Congress

Wolff-Winiski B: Identification of new therapeutics for chronic wounds through ex vivo assays with patient material.

Oct. 18-19, 2020

Oral presentation at European Wound Management Association (EWMA) meeting

Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B:
Screening of wound healing therapeutics with an ex vivo assay platform using wound exudates from individual patients.

Oct. 03, 2019

EU patent granted for theranostic assay platform